(Q37437155)

English

Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes

scientific article published on 14 September 2009

Statements

Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes (English)
Masahiro Yamamoto
Toru Yamaguchi
Mika Yamauchi
Toshitsugu Sugimoto
14 September 2009
2263-2268

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit